1GSK purchased 340,000 of its own ordinary shares on March 31, 2026, at a volume-weighted average price of 2,075.26p per share.
2The purchased shares will be held as Treasury shares, increasing the total treasury holdings to 256,112,615 ordinary shares.
3The transaction was part of the company's existing buyback programme and executed through BNP Paribas SA under a non-discretionary agreement announced on February 17, 2026.
4Since February 17, 2026, the company has purchased a cumulative total of 16,221,521 ordinary shares under this programme.
5Following the purchase, the total number of voting rights in the company is 4,060,067,166, with treasury shares representing 6.31% of voting rights.